Protalix Biotherapeutics, Inc. (PLX)
1.745
0.00 (0.00%)
USD |
NYAM |
Dec 09, 16:00
1.745
0.00 (0.00%)
After-Hours: 19:08
Protalix Biotherapeutics EPS Diluted (Quarterly): 0.0291 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| GlucoTrack, Inc. | -4.638 |
| PAVmed, Inc. | -0.2936 |
| AIM ImmunoTech, Inc. | -1.569 |
| Perspective Therapeutics, Inc. | -0.3495 |
| Armata Pharmaceuticals, Inc. | -0.7363 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 2.355M |
| Revenue (Quarterly) | 17.85M |
| Total Expenses (Quarterly) | 15.50M |
| Enterprise Value | 118.74M |
| Gross Profit Margin (Quarterly) | 53.37% |
| Profit Margin (Quarterly) | 13.19% |
| Earnings Yield | 3.98% |
| Operating Earnings Yield | 4.64% |
| Normalized Earnings Yield | 3.983 |